Explore evidence

42.7 %Mycobacterium tuberculosis drug resistance among HIV-positive patients in Western Kenya was prevalent in all 10 counties surveyed, with 42.7% of study samples resistant to at least one antituberculosis drug.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

87 isolatesIn Western Kenya, the T lineage accounted for 87 isolates (15.7%) of Mycobacterium tuberculosis.

Kenyatuberculosepublished 2023BMC pulmonary medicinePubMeddocument of 5 observations

0.89 %Among 4708 PLHIV initiated on IPT in Kenya between July 2015 and June 2018, 42 (0.89%) developed active tuberculosis.

Kenyatuberculose · VIH/sidaobserved July 2015 to June 2018published 2020PloS onePubMeddocument of 8 observations

53.2 %Mycobacterium tuberculosis drug resistance among HIV-negative patients in Western Kenya was prevalent in all 10 counties surveyed, with 53.2% of study samples resistant to at least one antituberculosis drug.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

14.6 %Resistance to rifampicin (RIF) among HIV-positive tuberculosis patients in Western Kenya was 14.6%.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

92.5 %Among 4708 PLHIV initiated on IPT in Kenya between July 2015 and June 2018, 4356 (92.5%) had ever been screened for tuberculosis at every clinic visit.

Kenyatuberculose · VIH/sidaobserved July 2015 to June 2018published 2020PloS onePubMeddocument of 8 observations

13.5 %Mtb infection prevalence at 12-month follow-up was 13.5% in the no INH arm among 133 infants.

Kenyatuberculosepublished 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument of 10 observations

12.2 %In 2015, 12.2% of adult TB cases in Kenya had an Xpert® test done.

Kenyatuberculoseobserved 2015published 2018BMC infectious diseaseseurope_pmcdocument of 12 observations

40.8 %Among 152 children with HIV, 40.8% (62) received tuberculosis–antiretroviral therapy co-treatment.

Kenyatuberculose · VIH/sidapublished 2024AIDS (London, England)PubMeddocument of 5 observations

17 individualsHLA-DQB1 and HLA-DRB1 alleles were analyzed in 17 pulmonary tuberculosis (PTB) patients.

Kenyatuberculosepublished 2022The Pan African medical journalPubMeddocument of 6 observations

0.56 odds_ratioHIV infection was associated with lower odds of completing TB treatment compared to HIV-negative status (adjusted odds ratio 0.56).

Kenyatuberculose · VIH/sidaobserved 2012–2020published 2023BMC infectious diseasesPubMeddocument of 11 observations

0.7 %Among HIV-negative tuberculosis patients in Western Kenya, INH + KAN polyresistant strains occurred in 0.7% of cases.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 23 observations

19 %Of those tested for tuberculosis (TB), 19% tested positive in Kenya.

Kenyatuberculosepublished 2020BMJ openPubMeddocument of 12 observations

37 %Among 1,047,406 people reported with TB in Kenya between 2008 and 2018, 37% of those who knew their HIV status were HIV-positive.

Kenyatuberculose · VIH/sidaobserved 2008 to 2018published 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument of 8 observations

30 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients aged 15–49 years in Kenya between 2012 and 2015, 30% of men and 17% of women were aged ≥40 years.

Kenyatuberculose · VIH/sidaobserved 2012-2015published 2020PloS onePubMeddocument of 6 observations

61.1 %GeneXpert sensitivity in smear negative culture positive specimens was 61.1%, compared to 54.5% for ZN microscopy and 54.5% for LED fluorescent microscopy.

Kenyatuberculoseobserved 2013-2014published 2019African Journal of Health SciencesOpenAlexdocument of 6 observations

80 %The sensitivity of C-reactive protein ≥3.3 mg/L for identifying pulmonary tuberculosis was 80% among people living with HIV receiving antiretroviral therapy in western Kenya.

Kenyatuberculosepublished 2021BMC infectious diseasesPubMeddocument of 12 observations

0.74 per_100000In 2015, there were 304 chest X-ray facilities in Kenya, with a mean density of 0.74 per 100,000 inhabitants.

Kenyatuberculoseobserved 2015published 2018BMC infectious diseaseseurope_pmcdocument of 12 observations

3.4 %Cryptococcus spp. was isolated from 3 out of 88 fungal-positive sputum samples (3.4%) among PTB patients in Kenya.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

8 %The prevalence of confirmed tuberculosis was 8% among 168 hospitalized antiretroviral therapy-naive Kenyan children with HIV.

Kenyatuberculosepublished 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 5 observations

1.2 %Three of 251 infants (1.2%) were QFT-Plus positive.

Kenyatuberculosepublished 2021The Pediatric infectious disease journalPubMeddocument of 3 observations

5.7 %Candida glabrata was isolated from 5 out of 88 fungal-positive sputum samples (5.7%) among PTB patients in Kenya.

Kenyatuberculosepublished 2022BMC infectious diseasesPubMeddocument of 14 observations

12.2 %A total of 75 (12.2%) of the 617 participants presented with presumptive Mycobacterium tuberculosis and had TB-like symptoms.

Kenyatuberculoseobserved July 2021 to June 2022published 2023Ethiopian journal of health sciencesPubMeddocument of 9 observations

100 %Sensitivity among people living with HIV with suspected tuberculosis was 100% versus sputum Xpert alone.

Kenyatuberculose · VIH/sidapublished 2022PloS onePubMeddocument of 10 observations

37.2 per_100000The median TB case notification rate among children aged 0–14 years in Kenya was 37.2 per 100,000 in 2015.

Kenyatuberculoseobserved 2015published 2018BMC infectious diseaseseurope_pmcdocument of 12 observations